Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients

References

• DelattreJYKrolGThalerHTPosnerJBDistribution of brain metastasesArch Neurol19884577417443390029
   PubMedGoogle Scholar
• LangerCJMehtaMPCurrent management of brain metastases, with a focus on systemic optionsJ Clin Oncol200523256207621916135488
   PubMed Web of Science ®Google Scholar
• PatchellRABrain metastasesNeurol Clin1991948178241758427
   PubMed Web of Science ®Google Scholar
• GasparLEMehtaMPPatchellRAThe role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineJ Neurooncol2010961173219960231
   PubMed Web of Science ®Google Scholar
• KhuntiaDBrownPLiJMehtaMPWhole-brain radiotherapy in the management of brain metastasisJ Clin Oncol20062481295130416525185
   PubMed Web of Science ®Google Scholar
• EichlerAFLoefflerJSMultidisciplinary management of brain metastasesOncologist200712788489817673619
   PubMed Web of Science ®Google Scholar
• AntonadouDParaskevaidisMSarrisGPhase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastasesJ Clin Oncol200220173644365012202665
   PubMed Web of Science ®Google Scholar
• ChuaDKrzakowskiMChouaidCWhole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II studyClin Lung Cancer201011317618120439193
   PubMed Web of Science ®Google Scholar
• CortesJRodriguezJAramendiaJMFront-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancerOncology2003641283512457029
   PubMed Web of Science ®Google Scholar
• GuerrieriMWongKRyanGA randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lungLung Cancer200446110711115364138
   PubMed Web of Science ®Google Scholar
• UshioYAritaNHayakawaTChemotherapy of brain metastases from lung carcinoma: a controlled randomized studyNeurosurgery19912822012051997887
   PubMed Web of Science ®Google Scholar
• VergerEGilMYayaRTemozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trialInt J Radiat Oncol Biol Phys200561118519115629610
   PubMed Web of Science ®Google Scholar
• BearzAGarassinoITiseoMActivity of pemetrexed on brain metastases from non-small cell lung cancerLung Cancer201068226426819632738
   PubMed Web of Science ®Google Scholar
• CeresoliGLCappuzzoFGregorcVGefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trialAnn Oncol20041571042104715205197
   PubMed Web of Science ®Google Scholar
• KimJELeeDHChoiYEpidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasisLung Cancer200965335135419157632
   PubMed Web of Science ®Google Scholar
• NambaYKijimaTYokotaSGefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical casesClin Lung Cancer20046212312815476598
   PubMedGoogle Scholar
• WuCLiYLWangZMGefitinib as palliative therapy for lung adenocarcinoma metastatic to the brainLung Cancer200757335936417434236
   PubMed Web of Science ®Google Scholar
• WuYLZhouCChengYErlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803)Ann Oncol201324499399923129122
   PubMed Web of Science ®Google Scholar
• NewtonCRGrahamAHeptinstallLEAnalysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)Nucleic Acids Res1989177250325162785681
   PubMed Web of Science ®Google Scholar
• GasparLScottCRotmanMRecursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trialsInt J Radiat Oncol Biol Phys19973747457519128946
   PubMed Web of Science ®Google Scholar
• GasparLEScottCMurrayKCurranWValidation of the RTOG recursive partitioning analysis (RPA) classification for brain metastasesInt J Radiat Oncol Biol Phys20004741001100610863071
   PubMed Web of Science ®Google Scholar
• SperdutoPWBerkeyBGasparLEMehtaMCurranWA new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG databaseInt J Radiat Oncol Biol Phys200870251051417931798
   PubMed Web of Science ®Google Scholar
• ZimmSWamplerGLStableinDHazraTYoungHFIntracerebral metastases in solid-tumor patients: natural history and results of treatmentCancer19814823843947237407
   PubMed Web of Science ®Google Scholar
• RudermanNBHallTCUse of glucocorticoids in the palliative treatment of metastaic brain tumorsCancer1965829830614264031
   PubMed Web of Science ®Google Scholar
• MoscettiLNelliFFeliciAUp-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in OncologyCancer2007109227428117154161
   PubMed Web of Science ®Google Scholar
• RobinetGThomasPBretonJLResults of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneu-mo-Cancerologie (GFPC) Protocol 95-91Ann Oncol2001121596711249050
   PubMed Web of Science ®Google Scholar
• BarlesiFGervaisRLenaHPemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)Ann Oncol201122112466247021321089
   PubMed Web of Science ®Google Scholar
• WelshJWKomakiRAminiAPhase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancerJ Clin Oncol201331789590223341526
   PubMed Web of Science ®Google Scholar
• MatsumotoSTakahashiKIwakawaRFrequent EGFR mutations in brain metastases of lung adenocarcinomaInt J Cancer200611961491149416642476
   PubMed Web of Science ®Google Scholar
• MokTSWuYLThongprasertSGefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaN Engl J Med20093611094795719692680
   PubMed Web of Science ®Google Scholar
• PortaRSanchez-TorresJMPaz-AresLBrain metastases from lung cancer responding to erlotinib: the importance of EGFR mutationEur Respir J201137362463120595147
   PubMed Web of Science ®Google Scholar
• ParkSJKimHTLeeDHEfficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutationLung Cancer201277355656022677429
   PubMed Web of Science ®Google Scholar
• MaSXuYDengQYuXTreatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and gefitinib in a Chinese populationLung Cancer200965219820319091441
   PubMed Web of Science ®Google Scholar
• BroniscerAPanettaJCO’ShaughnessyMPlasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420Clin Cancer Res20071351511151517332296
   PubMed Web of Science ®Google Scholar
• ZhaoJChenMZhongWCerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinomaClin Lung Cancer201314218819322846582
   PubMed Web of Science ®Google Scholar
• DaiHChenYElmquistWFDistribution of the novel antifolate pemetrexed to the brainJ Pharmacol Exp Ther2005315122222915987831
   PubMed Web of Science ®Google Scholar
• SanghaviSNMiranpuriSSChappellRRadiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis methodInt J Radiat Oncol Biol Phys200151242643411567817
   PubMed Web of Science ®Google Scholar
• FrazierJLBatraSKaporSStereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survivalInt J Radiat Oncol Biol Phys20107651486149219619958
   PubMed Web of Science ®Google Scholar
• SperdutoPWChaoSTSneedPKDiagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patientsInt J Radiat Oncol Biol Phys201077365566119942357
   PubMed Web of Science ®Google Scholar
• SperdutoPWKasedNRobergeDSummary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastasesJ Clin Oncol201230441942522203767
   PubMed Web of Science ®Google Scholar